1,721,338 research outputs found
sj-xls-1-inq-10.1177_00469580231219094 – Supplemental material for Study of Factors to Increase the Usage Rate of Generic Drugs in Platelet Aggregation Inhibitors
No full textSupplemental material, sj-xls-1-inq-10.1177_00469580231219094 for Study of Factors to Increase the Usage Rate of Generic Drugs in Platelet Aggregation Inhibitors by Takaaki Suzuki, Mari Iwata, Mika Maezawa, Kiyoka Matsumoto, Mizuki Tanaka, Riko Satake, Misaki Inoue, Yu Yoshida, Kazuhiro Iguchi and Mitsuhiro Nakamura in INQUIRY: The Journal of Health Care Organization, Provision, and Financing</p
180324supplementary1Table_02] – Supplemental material for Analysis of adverse events of renal impairment related to platinum-based compounds using the Japanese Adverse Drug Event Report database
No full textSupplemental material, 180324supplementary1Table_02 for Analysis of adverse events of renal impairment related to platinum-based compounds using the Japanese Adverse Drug Event Report database by Misa Naganuma, Yumi Motooka, Sayaka Sasaoka, Haruna Hatahira, Shiori Hasegawa, Akiho Fukuda, Satoshi Nakao, Kazuyo Shimada, Koseki Hirade, Takayuki Mori, Tomoaki Yoshimura, Takeshi Kato and Mitsuhiro Nakamura in SAGE Open Medicine</p
181227S1fig – Supplemental material for Adverse event profiles of solvent-based and nanoparticle albumin-bound paclitaxel formulations using the Food and Drug Administration Adverse Event Reporting System
No full textSupplemental material, 181227S1fig for Adverse event profiles of solvent-based and nanoparticle albumin-bound paclitaxel formulations using the Food and Drug Administration Adverse Event Reporting System by Misa Naganuma, Kohei Tahara, Shiori Hasegawa, Akiho Fukuda, Sayaka Sasaoka, Haruna Hatahira, Yumi Motooka, Satoshi Nakao, Ririka Mukai, Kouseki Hirade, Tomoaki Yoshimura, Takeshi Kato, Hirofumi Takeuchi and Mitsuhiro Nakamura in SAGE Open Medicine</p
190124S1Table – Supplemental material for Adverse event profiles of solvent-based and nanoparticle albumin-bound paclitaxel formulations using the Food and Drug Administration Adverse Event Reporting System
No full textSupplemental material, 190124S1Table for Adverse event profiles of solvent-based and nanoparticle albumin-bound paclitaxel formulations using the Food and Drug Administration Adverse Event Reporting System by Misa Naganuma, Kohei Tahara, Shiori Hasegawa, Akiho Fukuda, Sayaka Sasaoka, Haruna Hatahira, Yumi Motooka, Satoshi Nakao, Ririka Mukai, Kouseki Hirade, Tomoaki Yoshimura, Takeshi Kato, Hirofumi Takeuchi and Mitsuhiro Nakamura in SAGE Open Medicine</p
Imatinib sensitizes endometrial cancer cells to cisplatin by targeting CD117-positive growth-competent cells
No full text博士論文本文Full 以下に掲載：Cancer Letters 345(1) pp.106-114 2014. ELSEVIER. 共著者：Xiuzhi Zhang, Satoru Kyo, Mitsuhiro Nakamura, Yasunari Mizumoto, Yoshiko Maida, Yukiko Bono, Masahiro Takakura, Hiroshi Fujiwar
Going Beyond Counting First Authors in Author Co-citation Analysis
Full text linkThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
Mucinous, endometrioid, and serous ovarian cancers with peritoneal dissemination are potent candidates for P-cadherin targeted therapy: a retrospective cohort study
Full text link金沢大学博士(医学）博士論文 要旨Abstract/本文Full 以下に掲載：BMC Cancer 21(1) pp.32- 2021. BMC. 共著者：Kayo Kayahashi, Yasunari Mizumoto, Ayumi Matsuoka, Takeshi Obata, Junpei Iwadare, Mitsuhiro Nakamura, Takiko Daikoku, Hiroshi Fujiwaradoctoral thesi
Mucinous, endometrioid, and serous ovarian cancers with peritoneal dissemination are potent candidates for P-cadherin targeted therapy: a retrospective cohort study
No full text博士論文 要旨Abstract/本文Full 以下に掲載：BMC Cancer 21(1) pp.32- 2021. BMC. 共著者：Kayo Kayahashi, Yasunari Mizumoto, Ayumi Matsuoka, Takeshi Obata, Junpei Iwadare, Mitsuhiro Nakamura, Takiko Daikoku, Hiroshi Fujiwar
Dual expression of immunoreactive estrogen receptor β and p53 is a potential predictor of regional lymph node metastasis and postoperative recurrence in endometrial endometrioid carcinoma
Full text link金沢大学博士（医学）博士論文要旨Abstract 以下に掲載：PLOS ONE 12(11) pp. e0188641 2017. PLOS. 共著者：Takeshi Obata, Mitsuhiro Nakamura, Yasunari Mizumoto, Takashi Iizuka, Masanori Ono, Jumpei Terakawa, Takiko Daikoku, Hiroshi Fujiwarathesi
- …
